showed that higher baseline IL-1α levels were associated with improved outcomes in patients with oligometastatic NSCLC, possibly due to a systemic anti-tumor inflammatory state exhibited by induction chemotherapy (36). This evidence concerns the gene IL1A and neoplasm.